What this Study Startup screenshot shows
This reference interface displays the Site Activation Progress dashboard within Veeva Vault Study Startup, focusing on the site greenlight and essential document collection workflow. The screen presents a structured matrix tracking the completion status of critical milestones and essential documents across multiple clinical trial sites in the United States. Sites are categorized into distinct groups based on their Site Initiation Visit (SIV) status, including SIV Overdue, SIV Planned, and SIV Complete. By organizing site readiness metrics into a visual grid of color-coded status indicators, the interface provides clinical operations teams with a centralized view of outstanding requirements. This layout helps track progress toward site activation by highlighting completed, pending, and missing documentation, such as investigator CVs, protocol signature pages, and institutional review board approvals, for each participating site.
Visible interface elements
- Site Activation Progress title with breadcrumbs indicating the United States country view.
- SIV Overdue, SIV Planned, and SIV Complete grouping headers with site counts.
- Color-coded status icons including solid green, half-filled orange, and empty red circles.
- Columns for essential documents such as Form FDA 1572, Budget, and Protocol Signature Page.
- Left-hand sidebar containing filters for Study Country and Study Site.
- Sort dropdown configured to display Planned SIV Date with oldest first.
- Top navigation bar featuring Vault Clinical modules like Study Startup and Reports.
Interface details
The interface features a multi-column grid layout under the main header of Veeva Vault Clinical. A left-hand navigation panel displays options for Study Country, Study Site, Views, and Filters, showing that the current view is filtered for the United States under study code AVDS 027. The central workspace displays the Site Activation Progress matrix, sorted by the oldest planned SIV date. The matrix columns represent specific milestone types, essential documents, and greenlight requirements, such as Form FDA 1572, informed consent forms, and budget agreements. Rows represent individual sites, identified by synthetic codes like US-101 and US-104, grouped into SIV Overdue, SIV Planned, and SIV Complete sections. Statuses are represented visually using color-coded icons: solid green circles indicate completed items, half-filled orange circles represent in-progress tasks, and empty red circles denote outstanding or missing requirements. Dashes indicate items that are not applicable or have no recorded data. A horizontal scrollbar at the bottom allows users to navigate through the extensive list of tracked documents and milestones.
Workflow context
In clinical trial operations, managing the site greenlight process is critical to ensuring that sites are fully compliant before initiating patient enrollment. This dashboard can support study startup managers in identifying bottlenecks that delay site activation. For instance, the SIV Overdue section highlights sites that have missed their planned initiation dates, allowing coordinators to quickly see which specific documents, such as IRB approvals or financial agreements, are holding up the greenlight. Conversely, the SIV Complete section displays sites that have successfully met their requirements, providing a historical record of completed milestones. By presenting these status indicators side by side, the interface could help clinical teams prioritize follow-up actions, allocate resources to struggling sites, and maintain visibility over the critical path to trial initiation across a country or region.
Source, version, and interpretation limits
The screenshot is sourced from a Veeva Study Startup datasheet and represents a 2020-era user interface. As a static visual representation, this image cannot confirm real-time data synchronization, automated status updates, or active integration with external clinical systems. The displayed data, including site numbers, dates, and milestone statuses, is synthetic demonstration data used for illustrative purposes. Actual field labels, available filters, document categories, and overall layout configurations may vary depending on the specific software release, organization-specific configurations, and regional study requirements. The presence of completed indicators does not verify regulatory compliance or the validity of the underlying documents.
Authoritative references
Use these primary sources to confirm current product positioning, terminology, and release-specific behavior.
- Veeva Study Startup datasheet(Official Veeva PDF)
- Veeva Study Startup product overview(Official Veeva product page)
- Veeva Study Startup features(Official Veeva resource)
